1302 — LifeTech Scientific Cashflow Statement
0.000.00%
- HK$6.67bn
- HK$5.99bn
- CNY1.30bn
- 72
- 27
- 52
- 51
Annual cashflow statement for LifeTech Scientific, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 243 | 333 | 378 | 176 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 16.2 | -3.9 | 86.1 | 272 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 22.7 | 55.7 | -136 | -98.3 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 339 | 441 | 388 | 418 | — |
Capital Expenditures | -105 | -276 | -226 | -206 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -237 | 237 | -232 | -248 | — |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -342 | -39 | -458 | -454 | — |
Financing Cash Flow Items | -10.2 | 14.7 | 0.158 | 10.8 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 675 | -256 | -215 | 183 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 673 | 148 | -285 | 146 | — |